REVOLAX™ FINE with Lidocaine

When you purchase a box of Revolax Fine with Lidocaine, you get 1 prefilled syringe that has 1.1ml of filler material, 2 single-use and sterilized 30G needles, and a package insert. In general, results will last 12-18 months.

• Treatment areas: crow’s feet, glabellar lines, neck wrinkles
• Designed for the treatment of superficial lines

REVOLAX™ FINE lidocaine is a sterile, pyrogen-free, physiological gel of cross-linked 24mg/ml hyaluronic acid of non-animal origin with the addition of 0.3% lidocaine hydrochloride. It is a colourless, unscented and highly viscous aqueous gel.

This aesthetic implant is composed of highly structured monophasic and densely linked hyaluronic acid polymers that instantly erase superficial wrinkles with natural-looking results. As the name suggests, this filler targets fine lines, such as crow’s feet, neck wrinkles, forehead lines, and perioral lines.

REVOLAX FINE lidocaine is provided as a sterile volume of 1.1 ml in a single-use glass syringe with two sterilized needles.

When using REVOLAX™ FINE with Lidocaine, it is recommended to inject the filler slowly into the dermis using the appropriate technique, such as the linear threading technique or a series of spot injections with the provided syringe. The soft tissue implant is indicated to be injected into the superficial dermis layer of the skin, and practitioners should adhere to the exact injection technique, appropriate for the area chosen.

Contraindications:

• Do not inject REVOLAX DEEP Lidocaine into the eye area (eye circle or eyelids).
• Do not inject REVOLAX DEEP Lidocaine into the blood vessels (intravascular).
• REVOLAX DEEP Lidocaine should not be used in:
  • Pregnant or nursing women
  • Persons under 18 years of age
  • Patients known to be hypersensitive to hyaluronic acid
  • Patients who tend to develop hypertrophic scars.
  • REVOLAX DEEP Lidocaine should not be used in combination with laser therapy, chemical peeling, or skin abrasion.
  • REVOLAX DEEP Lidocaine should not be used in areas with inflammatory and infectious skin problems.
  • The total dose of lidocaine administered should be considered if a dental block or topical administration of lidocaine are used simultaneously. High doses of lidocaine (more than 400 mg) may cause acute toxic reactions with symptoms affecting the central nervous system and cardiac conduction.
  • Lidocaine should be used with caution in patients receiving other local anaesthetics or structural agents such as some anti-arrhythmics, as systemic toxicity may be additive.
  • Lidocaine should be used with caution in patients with epilepsy, altered cardiac conduction, severe alteration of liver function, or severe renal dysfunction. Peribulbar injections of local anaesthetics carry a small risk of persistent ocular muscle dysfunction.

After-care:

• Do not use in patients with coagulation disorders or in patients who have been treated with thrombolytic anticoagulants or platelet aggregation inhibitors within the previous 2 weeks.
• It is recommended to avoid taking aspirin, non-steroidal anti-inflammatory drugs or high doses of vitamin C the week before the injection.
• Patients are advised not to wear make-up for 12 hours after the injection and to avoid extended exposure to sunlight, UV light, and extreme cold and heat for 2 weeks after the injection.